MarketPulse

FDA disclosure

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

Corcept Stock Crashes 50% After FDA Rejection; Class Action Lawsuit Filed

Hagens Berman launches securities class action against $CORT after FDA rejects lead drug relacorilant, citing insufficient evidence. Stock plummeted 50% on December 31, 2025.
CORTsecurities class actionrelacorilant
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

Soleno's VYKAT XR Faces Legal Storm as Safety Concerns Tank Stock 40%

Soleno Therapeutics faces securities lawsuit after hyperphagia drug VYKAT XR launch falters amid safety concerns, driving shares down 40% since August short seller report.
SLNOstock declinesecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

Soleno Therapeutics Faces Class Action Over DCCR Safety Claims as Stock Plummets

Soleno Therapeutics faces class action lawsuit over DCCR safety concealment claims, with investors suffering significant losses following critical short-seller report and patient death disclosure.
SLNOsecurities fraudclass action lawsuit